Literature DB >> 27226155

Stem cells: The cancer's gone, but did chemotherapy damage your heart?

Milena Bellin1, Christine L Mummery1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27226155     DOI： 10.1038/nrcardio.2016.88

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

Review 1.  Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.

Authors:  Mahwash F Saeed; Sheena Premecz; Vineet Goyal; Pawan K Singal; Davinder S Jassal
Journal:  Can J Physiol Pharmacol       Date:  2014-01-31       Impact factor: 2.273

Review 2.  Doxorubicin-induced cardiomyopathy.

Authors:  P K Singal; N Iliskovic
Journal:  N Engl J Med       Date:  1998-09-24       Impact factor: 91.245

Review 3.  Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?

Authors:  Christiaan C Veerman; Georgios Kosmidis; Christine L Mummery; Simona Casini; Arie O Verkerk; Milena Bellin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

4.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

Review 5.  Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors:  Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal:  Nat Rev Clin Oncol       Date:  2015-10-13       Impact factor: 66.675

6.  Decline in the use of anthracyclines for breast cancer.

Authors:  Sharon H Giordano; Yu-Li Lin; Yong Fang Kuo; Gabriel N Hortobagyi; James S Goodwin
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

7.  Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.

Authors:  Paul W Burridge; Yong Fuga Li; Elena Matsa; Haodi Wu; Sang-Ging Ong; Arun Sharma; Alexandra Holmström; Alex C Chang; Michael J Coronado; Antje D Ebert; Joshua W Knowles; Melinda L Telli; Ronald M Witteles; Helen M Blau; Daniel Bernstein; Russ B Altman; Joseph C Wu
Journal:  Nat Med       Date:  2016-04-18       Impact factor: 53.440

Review 8.  New signal transduction paradigms in anthracycline-induced cardiotoxicity.

Authors:  Alessandra Ghigo; Mingchuan Li; Emilio Hirsch
Journal:  Biochim Biophys Acta       Date:  2016-01-29

9.  Genetic background drives transcriptional variation in human induced pluripotent stem cells.

Authors:  Foad Rouhani; Natsuhiko Kumasaka; Miguel Cardoso de Brito; Allan Bradley; Ludovic Vallier; Daniel Gaffney
Journal:  PLoS Genet       Date:  2014-06-05       Impact factor: 5.917
  9 in total
  5 in total

1.  Multimodality imaging in the assessment of bone marrow-derived mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathy.

Authors:  Chanjuan Qu; Jian Wang; Yuqing Wang; Fangfei He; Xudong Shi; Zhuoli Zhang; Yining Wang
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 2.  Inherited heart disease - what can we expect from the second decade of human iPS cell research?

Authors:  Milena Bellin; Christine L Mummery
Journal:  FEBS Lett       Date:  2016-07-22       Impact factor: 4.124

Review 3.  MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo.

Authors:  Luca Sala; Berend J van Meer; Leon G J Tertoolen; Jeroen Bakkers; Milena Bellin; Richard P Davis; Chris Denning; Michel A E Dieben; Thomas Eschenhagen; Elisa Giacomelli; Catarina Grandela; Arne Hansen; Eduard R Holman; Monique R M Jongbloed; Sarah M Kamel; Charlotte D Koopman; Quentin Lachaud; Ingra Mannhardt; Mervyn P H Mol; Diogo Mosqueira; Valeria V Orlova; Robert Passier; Marcelo C Ribeiro; Umber Saleem; Godfrey L Smith; Francis L Burton; Christine L Mummery
Journal:  Circ Res       Date:  2017-12-27       Impact factor: 17.367

Review 4.  Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

Authors:  Luca Sala; Milena Bellin; Christine L Mummery
Journal:  Br J Pharmacol       Date:  2016-09-20       Impact factor: 8.739

Review 5.  Recent advances for cancer detection and treatment by microfluidic technology, review and update.

Authors:  Nasrin Bargahi; Samaneh Ghasemali; Samaneh Jahandar-Lashaki; Atefeh Nazari
Journal:  Biol Proced Online       Date:  2022-04-28       Impact factor: 7.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.